Transepithelial Transport of Prodrugs of the HIV Protease Inhibitors Saquinavir, Indinavir, and Nelfinavir Across Caco-2 Cell Monolayers
Authors:
- 1 November 2002
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 19 (11) , 1704-1712
Abstract
Purpose. This study is dedicated to the permeation of various amino acid-, D-glucose-, and PEG-conjugates of indinavir, saquinavir, and nelfinavir across monolayers of Caco-2 cells as models of the...Keywords
This publication has 20 references indexed in Scilit:
- Transporter-Mediated Permeation of Drugs Across the Blood–Brain BarrierJournal of Pharmaceutical Sciences, 2000
- The Influence of Donor and Reservoir Additives on Caco-2 Permeability and Secretory Transport of HIV Protease Inhibitors and Other Lipophilic CompoundsPharmaceutical Research, 2000
- Investigation of distribution, transport and uptake of anti-HIV drugs to the central nervous systemAdvanced Drug Delivery Reviews, 1999
- Prodrug Approaches to the Improved Delivery of Peptide DrugsCurrent Pharmaceutical Design, 1999
- Human Immunodeficiency Virus Protease InhibitorsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1999
- Comparison of the Disposition of Ester Prodrugs of the Antiviral Agent 9-(2-phosphonylmethoxyethyl)adenine [PMEA] in Caco-2 MonolayersPharmaceutical Research, 1998
- Clinical pharmacology of HIV protease inhibitors: focus on saquinavir, indinavir, and ritonavirInternational Journal of Clinical Pharmacy, 1997
- Age-dependent Expression of P-Glycoprotein gp17O in Caco-2 Cell MonolayersPharmaceutical Research, 1996
- Targeting HIV-1 protease: A test of drug-design methodologiesTrends in Pharmacological Sciences, 1995
- Cell cultures as models for drug absorption across the intestinal mucosa.1991